Australia Biotech Invest 2017
Connecting Capital with Innovation
24 October 2017
Sofitel Melbourne on Collins
Australian life science companies are invited to express their interest to present at Australia Biotech Invest, Australia’s life science investment event, to be held on 24 October in Melbourne.
The event will include a full-day program of company presentations, which will showcase the potential of life science companies to an anticipated 200 investors. A dedicated exhibition area will enable companies to display detailed information about their business case and technologies and engage directly with prospective partners.
Participating in Australia Biotech Invest will provide your company with a unique opportunity to connect with investors from Australia and around the world, and to take your business to the next level.
Contact email@example.com / +61 3 9828 1400 to find out more.
The AusBiotech-led Asian Investment Series confirmed that investor interest in the Australian life science industry is strong and intensifying.
Almost 400 delegates gathered to hear 21 Australian biotechnology and medical technology companies present their investment proposition as part of the Series, which was held in Singapore, Hong Kong and Shanghai during March.
AusBiotech CEO, Glenn Cross, who led the three events, said: "This strong investor interest in the Australian life sciences stems from the nation's top ranking in the global life sciences and its diverse suite of investment opportunities in biotechnology and pharmaceuticals."
Read the article, Asian Investor series confirms strong investor interest.
The events featured: